Racial and Ethnic Differences in Potentially Inappropriate Medication Use Among Medicare Beneficiaries
In this cross-sectional study of 32 199 587 Medicare beneficiary-years from 2016 to 2019, White Medicare beneficiaries had consistently higher rates of PIM use compared with other racial and ethnic groups. The observed differences may be partially explained by racial and ethnic differences in overall prescription drug use and suggest the need to reduce PIM use in all racial and ethnic groups.
Authors
- Wendy Xu (ORCID: https://orcid.org/0000-0002-7142-6784)
- Caroline Carlin (ORCID: https://orcid.org/0000-0003-0813-3433)
- Jeah Jung (ORCID: https://orcid.org/0000-0001-7574-0677)
- Sheldon M. Retchin (ORCID: https://orcid.org/0000-0003-3816-3529)
- Eli Raver (ORCID: https://orcid.org/0000-0002-6904-770X)
- Roger Feldman
Institutions
- University of Minnesota (US)
- George Mason University (US)
- Twin Cities Orthopedics (US)
- The Ohio State University (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-04-14
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.4763
- Citations
- 4
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 4.90
Funders
- Novo Nordisk
- National Institutes of Health